We have shown previously that EGFR and Bcl-xL are direct targets of miR-491-5p and that their concomitant inhibition with specific pharmacological inhibitors is able to mimic miR-491-5p-induced cell death in ovarian cancer cells [9]. This evidence concerns the gene BCL2L1 and ovarian carcinoma.